Standard Contracts
AMENDED AND RESTATED COLLABORATIVE LICENSE AGREEMENTCollaborative License Agreement • May 28th, 2021 • Ambrx Biopharma Inc. • Biological products, (no disgnostic substances) • California
This Amended and Restated Collaborative License Agreement (the “Agreement”) is entered into and made effective as of October 10, 2014 (the “Amended and Restated Effective Date”), by and between Ambrx, Inc., a Delaware corporation (“Ambrx”) located at 10975 North Torrey Pines Road, La Jolla, CA 92037, and The California Institute for Biomedical Research, a nonprofit public benefit corporation (“Institute”) located at 11119 North Torrey Pines Road, La Jolla, CA with respect to the facts set forth below. Each of Ambrx and Institute shall be called a “Party” and collectively the “Parties.”
BETWEENCollaborative License Agreement • May 22nd, 2000 • Dendreon Corp • Pharmaceutical preparations • California
CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Amendment No. 1 to...Collaborative License Agreement • May 2nd, 2014 • Ambrx Inc • Pharmaceutical preparations
This AMENDMENT NO. 1 TO COLLABORATIVE LICENSE AGREEMENT (the “Amendment No. 1”) is made and entered into as of April 10th, 2014 (the “Amendment No. 1 Effective Date”), by and between Ambrx, Inc., a Delaware corporation (“Ambrx”) located at 10975 North Torrey Pines Road, La Jolla, CA 92037, and The California Institute for Biomedical Research, a nonprofit public benefit corporation (“Institute”) located at 11119 North Torrey Pines Road, La Jolla, CA with respect to the facts set forth below. Each of Ambrx and Institute shall be called a “Party” and collectively the “Parties.”
EXHIBIT 10.13 AMENDED AND RESTATED COLLABORATIVE LICENSE AGREEMENTCollaborative License Agreement • March 14th, 2003 • Dendreon Corp • Pharmaceutical preparations • California
COLLABORATIVE LICENSE AGREEMENT Between Cerus Corporation And Kirin Brewery Company, LimitedCollaborative License Agreement • May 9th, 2001 • Cerus Corp • Biological products, (no disgnostic substances) • California
This Collaborative License Agreement (the "Agreement") is made and entered into effective as of December 31, 2000 (the "Effective Date") by and between Cerus Corporation, a Delaware corporation having its principal place of business at 2411 Stanwell Drive, Concord, California, U.S.A. ("Cerus"), and Kirin Brewery Company, Limited a corporation organized and existing under the laws of Japan having its principal place of business at 10-1, Shinkawa 2-chome, Chuo-ku, Tokyo, Japan ("Kirin"). Cerus and Kirin may be referred to herein collectively as the "Parties" or individually as a "Party."
